ADAMS ROBERT G - 08 Jun 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Reporting relationship: Director
Issuer ticker: NHC
Reported as of: 08 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 16:24:30 UTC
Prior SEC filing: 07 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Robert Adams

Key filing fact

ADAMS ROBERT G filed Form 4 for NATIONAL HEALTHCARE CORP (NHC) on 10 Jun 2026.

Key facts

This page summarizes ADAMS ROBERT G's Form 4 filing for NATIONAL HEALTHCARE CORP (NHC).
3 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 10 Jun 2026, 16:24.

Change

Previous filing in this sequence was filed on 07 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001012855 Primary reporting owner

ADAMS ROBERT G

Relationship: Director
Address: 100 VINE STREET, MURFREESBORO
Signature: /s/ Robert Adams
Signature date: 10 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NHC transaction

Shares of Common Stock - Trust I

Options Exercise

Transaction value
Shares: +4,000
Change %: +29%
Price: $69.19^*
Shares after: 17,579
Date: 08 Jun 2026
Ownership: Trustee
Footnotes: F1

NHC transaction

Shares of Common Stock - Trust I

Gift

Transaction value
Shares: -4,000
Change %: -23%
Price: $0.000000^*
Shares after: 13,579
Date: 08 Jun 2026
Ownership: Trustee
Footnotes: F2

NHC holding

Shares of Common Stock - Partnership

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 430,341
Date: 08 Jun 2026
Ownership: General Partner

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHC transaction Derivative

Option to Purchase Common Stock [2022 Grant]

Options Exercise

Transaction value
Shares: -4,000
Change %: -53%
Price: $0.000000^*
Shares after: 3,500
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $69.19
Footnotes: F1

NHC holding Derivative

Option to Purchase Common Stock [2023 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $55.75

NHC holding Derivative

Option to Purchase Common Stock [2024 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $96.03

NHC holding Derivative

Option to Purchase Common Stock [2025 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $94.66

NHC holding Derivative

Option to Purchase Common Stock [2026 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $171.42

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

Footnote F2

Total amount of shares beneficially owned following transactions reported on this form.